RGEN

Repligen Stock Analysis

AI Rating

Neutral
  • Quality6/10
  • Growth↑ 8/10
  • Value↓ 1/10
Repligen sales and earnings growth
RGEN Growth
Good
  • Revenue Y/Y↑ 17.36%
  • EPS Y/Y↑ 319.05%
  • FCF Y/Y↓ -10.37%
Repligen gross and profit margin trends
RGEN Profitability
Good
  • Gross margin ↑ 52.90%
  • EPS margin↓ 6.70%
  • ROIC 5Y↓ 5.43%
Repligen net debt vs free cash flow
RGEN Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 1.0
  • Interest coverage↓ 3.6

Repligen stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Instruments & Supplies stocks